[1]
2026. ANTI-GAD AND C-PEPTIDE IN EARLY-ONSET NON-OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR LADA SCREENING. Vietnam Journal of Community Medicine. 67, CĐ11-NCKH (July 2026). DOI:https://doi.org/10.52163/yhc.v67iCD11.6038.